Post-Extraction Bleeding in a Patient on Warfarin
A 68-year-old man underwent extraction of the mandibular right first molar 6 hours ago. He has a history of atrial fibrillation and takes warfarin 5 mg daily. His most recent INR, checked 3 days ago, was 3.2. The extraction was performed without incident, but he now presents with persistent oozing from the socket. He has changed gauze pads every 20 minutes for the past 2 hours. His blood pressure is 150/90 mmHg, and he is visibly anxious. He denies chest pain or shortness of breath. Intraoral examination reveals a blood clot in the socket but active bleeding from the gingival margin. His medications include warfarin, metoprolol, and atorvastatin. He has no known bleeding disorder.
1. What is your immediate management of the bleeding, and how do you address his anticoagulation?
Read the worked answer
Immediate management:
- Reassure the patient and check vital signs; his BP is elevated, which may contribute to bleeding.
- Remove the existing clot and irrigate the socket with saline to visualize the bleeding source.
- Apply pressure with a gauze soaked in tranexamic acid (if available) or plain gauze, biting firmly for 20–30 minutes.
- If bleeding persists, suture the socket with a figure-of-eight or interrupted sutures, and consider a hemostatic agent (e.g., oxidized cellulose, gelatin sponge) placed in the socket.
- Check INR immediately – if >4.0, consider reversing with vitamin K or fresh frozen plasma in consultation with hematology.
Anticoagulation:
- Do not stop warfarin abruptly; risk of thromboembolism.
- His INR of 3.2 is within therapeutic range for AF (2.0–3.0), but slightly elevated. For minor bleeding, local measures suffice.
- If bleeding cannot be controlled, consult his cardiologist/hematologist regarding temporary reversal.
- Arrange follow-up in 24 hours and advise avoiding hot liquids, smoking, and vigorous rinsing.
2. How would you modify your approach if he had taken a direct oral anticoagulant (DOAC) instead of warfarin?
Read the worked answer
DOAC considerations:
- DOACs (e.g., apixaban, rivaroxaban) have shorter half-lives and predictable pharmacokinetics; routine INR monitoring is not used.
- For minor bleeding, local measures are usually sufficient. Do not stop the DOAC without consulting the prescriber.
- If bleeding is severe, specific reversal agents (e.g., andexanet alfa for factor Xa inhibitors, idarucizumab for dabigatran) may be required.
- Timing of extraction: for DOACs, it is often safe to perform minor oral surgery without interruption, but for higher-risk procedures, the DOAC may be withheld for 1–2 half-lives (e.g., 24–48 hours) pre-operatively, depending on renal function and bleeding risk.
- Always liaise with the patient’s physician to balance bleeding vs. thrombotic risk.